Table 3.
Information on lung cancer samples in the test set.
| Project name | Subproject | Number/percentage |
|---|---|---|
| Lung cancer | Adenocarcinoma | 89 (54.6%) |
| Squamous carcinoma | 51 (31.3%) | |
| Other cancers | 23 (14.1%) | |
| Stage | Stage I | 67 (41.1%) |
| Stage II | 96 (58.9%) | |
| Gender | Male | 69 (42.3%) |
| Female | 94 (57.7%) |